Matthew L. Posard, Director: Halozyme Therapeutics HALO Planned sale · Filed 09/16

Trade details

Type: Planned sale notice
Stock: Halozyme Therapeutics HALO
Person: Matthew L. PosardDirector
Planned sale date: 26/09/16
Filed: 26/09/16

$3.6M to be sold

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 08/17~10/16

Matthew L. Posard's recent trades

Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$570.1K
9,881 sh
$570.1K
Filed 24/08/14
Traded 24/08/14
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$561.9K
10,000 sh
$561.9K
Filed 24/08/14
Traded 24/08/13
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$557.2K
10,000 sh
$557.2K
Filed 24/08/14
Traded 24/08/12
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$506.2K
10,000 sh
$506.2K
Filed 24/06/13
Traded 24/06/12
Matthew L. PosardDirector
SellHalozyme Therapeutics
Sell
Halozyme Therapeutics
HALO
$500.1K
10,000 sh
$500.1K
Filed 24/06/13
Traded 24/06/11

Matthew L. Posard, Director — plans to sell 34,226 sh of Halozyme Therapeutics HALO · $3.6M · around 09/16 · 10b5-1 plan | Whalegun